1. Home
  2. ANIP vs DRH Comparison

ANIP vs DRH Comparison

Compare ANIP & DRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • DRH
  • Stock Information
  • Founded
  • ANIP 2001
  • DRH 2004
  • Country
  • ANIP United States
  • DRH United States
  • Employees
  • ANIP N/A
  • DRH N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • DRH Real Estate Investment Trusts
  • Sector
  • ANIP Health Care
  • DRH Real Estate
  • Exchange
  • ANIP Nasdaq
  • DRH Nasdaq
  • Market Cap
  • ANIP 2.0B
  • DRH 1.8B
  • IPO Year
  • ANIP N/A
  • DRH 2005
  • Fundamental
  • Price
  • ANIP $84.04
  • DRH $8.96
  • Analyst Decision
  • ANIP Strong Buy
  • DRH Hold
  • Analyst Count
  • ANIP 7
  • DRH 6
  • Target Price
  • ANIP $99.29
  • DRH $8.88
  • AVG Volume (30 Days)
  • ANIP 413.5K
  • DRH 4.0M
  • Earning Date
  • ANIP 11-07-2025
  • DRH 11-06-2025
  • Dividend Yield
  • ANIP N/A
  • DRH 3.57%
  • EPS Growth
  • ANIP N/A
  • DRH N/A
  • EPS
  • ANIP 1.67
  • DRH 0.26
  • Revenue
  • ANIP $826,880,000.00
  • DRH $1,125,008,000.00
  • Revenue This Year
  • ANIP $40.23
  • DRH N/A
  • Revenue Next Year
  • ANIP $9.65
  • DRH $2.31
  • P/E Ratio
  • ANIP $50.17
  • DRH $34.80
  • Revenue Growth
  • ANIP 48.87
  • DRH 0.95
  • 52 Week Low
  • ANIP $52.50
  • DRH $6.19
  • 52 Week High
  • ANIP $99.50
  • DRH $10.00
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 29.50
  • DRH 68.52
  • Support Level
  • ANIP $79.39
  • DRH $7.58
  • Resistance Level
  • ANIP $95.45
  • DRH $9.42
  • Average True Range (ATR)
  • ANIP 4.46
  • DRH 0.29
  • MACD
  • ANIP -0.97
  • DRH 0.12
  • Stochastic Oscillator
  • ANIP 29.48
  • DRH 74.73

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About DRH Diamondrock Hospitality Company

Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.

Share on Social Networks: